Inhibrx Biosciences

Inhibrx Biosciences INBX Stock

$68.97   -7.211086%
Add to favorites
Market Cap
$1.02B
LOW - HIGH [24H]
$68.78 - $74.45
VOLUME [24H]
$252.13K
P/E Ratio
0
Earnings per share
-$9.06
ISIN
US45720N1037
Price   Prediction

Inhibrx Biosciences Price Chart

Sorry, that's all we've gotfor now...

Inhibrx Biosciences (INBX) stock price today is 68.97 USD on Tech Market Large (-7.21% on the day). Updated .

Inhibrx Biosciences INBX Financial and Trading Overview

Inhibrx Biosciences stock price 68.97 USD
Previous Close 74.33 USD
Open 72.72 USD
Bid 73.15 USD x 1000
Ask 93.63 USD x 200
Day's Range 68.78 - 74.45 USD
52 Week Range 57.3 - 155.29 USD
Volume 252.13K USD
Avg. Volume 305.96K USD
Market Cap 1.02B USD
Beta (5Y Monthly) 4.038
PE Ratio (TTM) N/A
EPS (TTM) -9.06 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 258.33 USD

INBX Valuation Measures

Enterprise Value 1.1B USD
Trailing P/E N/A
Forward P/E -8.196078
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 509.31158
Price/Book (mrq) N/A
Enterprise Value/Revenue 550.298
Enterprise Value/EBITDA -8.905

Trading Information

Inhibrx Biosciences Stock Price History

Beta (5Y Monthly) 4.038
52-Week Change -14.86%
S&P500 52-Week Change 3.06%
52 Week High 155.29 USD
52 Week Low 57.3 USD
50-Day Moving Average 91.17 USD
200-Day Moving Average 92.47 USD

INBX Share Statistics

Avg. Volume (3 month) 305.96K USD
Avg. Daily Volume (10-Days) 247.2K USD
Shares Outstanding 14.77M
Float 8.08M
Short Ratio 12.06
% Held by Insiders 23.00%
% Held by Institutions 91.78%
Shares Short 3.39M
Short % of Float 30.62%
Short % of Shares Outstanding 22.96%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) -6286.69%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -39.51%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 2M USD
Revenue Per Share (ttm) 0.13 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -98431000 USD
EBITDA -123596000 USD
Net Income Avi to Common (ttm) -141658000 USD
Diluted EPS (ttm) -9.06
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 199.47M USD
Total Cash Per Share (mrq) 13.51 USD
Total Debt (mrq) 281.44M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 7.577
Book Value Per Share (mrq) -5.819

Cash Flow Statement

Operating Cash Flow (ttm) -132670000 USD
Levered Free Cash Flow (ttm) -81109872 USD

Profile of Inhibrx Biosciences

Country United States
State CA
City La Jolla
Address 11025 North Torrey Pines Road
ZIP 92037
Phone 858 795 4220
Website https://inhibrx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 109

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.

Q&A For Inhibrx Biosciences Stock

What is a current INBX stock price?

Inhibrx Biosciences INBX stock price today per share is 68.97 USD.

How to purchase Inhibrx Biosciences stock?

You can buy INBX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Inhibrx Biosciences?

The stock symbol or ticker of Inhibrx Biosciences is INBX.

Which industry does the Inhibrx Biosciences company belong to?

The Inhibrx Biosciences industry is Biotechnology.

How many shares does Inhibrx Biosciences have in circulation?

The max supply of Inhibrx Biosciences shares is 14.77M.

What is Inhibrx Biosciences Price to Earnings Ratio (PE Ratio)?

Inhibrx Biosciences PE Ratio is now.

What was Inhibrx Biosciences earnings per share over the trailing 12 months (TTM)?

Inhibrx Biosciences EPS is -9.06 USD over the trailing 12 months.

Which sector does the Inhibrx Biosciences company belong to?

The Inhibrx Biosciences sector is Healthcare.

Inhibrx Biosciences INBX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Global Market Composite NQGM US 1743.91 USD —
-3.66
— — 1738.23 USD — 1808.43 USD — — — —
us US Tech Biotechnology NBI US 6781.89 USD —
-1.73
— — 6767.31 USD — 6980.47 USD — — — —
$2.08T
Total marketcap
$111.52B
Total volume
BTC 57.91%   •   ETH 9.84%
Dominance
Select currency